IL-2: A two-faced master regulator of autoimmunity

Journal of Autoimmunity

Volumn 36, Issue 2, 2011, Pages 91-97

  Sharma, Rahul ^a   Fu, Shu Man ^a   Ju, Shyr Te ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Autoimmunity; IL 2; Inflammation; Regulatory T cells; Scurfy; Th cytokines; Trafficking

Indexed keywords

ANTIGEN; GLUTAMATE DECARBOXYLASE; INTERLEUKIN 2; PROINSULIN; RAPAMYCIN;

ADAPTIVE IMMUNITY; ANTIGEN SPECIFICITY; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GENETIC ANALYSIS; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LOW DRUG DOSE; LYMPHOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; TH2 CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; AUTOIMMUNITY; HUMANS; INFLAMMATION; INTERLEUKIN-2; MICE; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 79951952929     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.01.001     Document Type: Review

References (46)

1. Wing K., Fehervari Z., Sakaguchi S. Emerging possibilities in the development and function of regulatory T cells. Int Immunol 2006, 18:991-1000.
2. + regulatory T cells control autoimmunity?. Curr Opin Immunol 2005, 17:638-642.
3. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 2004, 16:81-88.
4. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993, 75:253-261.
5. Gaffen S.L., Liu K.D. Overview of interleukin-2 function, production and clinical applications. Cytokine 2004, 28:109-123.
6. + T cells in Scurfy mice that display both CD103-dependent and independent inflammation. J Immunol 2009, 183:1065-1073.
7. Sharma R., Sharma P.R., Kim Y.-C., Leitinger N., Lee J.K., Fu S.M., et al. IL-2-controlled expression of multiple T-cell trafficking genes and Th2 cytokines in the regulatory T-cell deficient Scurfy mice: Implication to multi-organ inflammation and control of skin and lung inflammation. J Immunol 2011, 186:1268-1278.
8. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341.
9. + regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 2005, 6:1152-1159.
10. Fontenot J.D., Rasmussen J.P., Gavin M., Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005, 6:1142-1151.
11. + regulatory T-cells. J Immunol 2007, 178:280-290.
12. Lio C.W., Hsueh C.S. A two-step process for thymic regulatory T cell development. Immunity 2008, 28:100-111.
13. Burchill M.A., Yang J., Vang K.B., Moon J.J., Chu H.H., Lio C.S., et al. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 2008, 28:112-121.
14. Fontenot J.D., Dooley J.L., Farr A.G., Rudensky A.Y. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 2005, 202:901-906.
15. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
16. + regulatory T cells: more of the same or a division of labor?. Immunity 2009, 30:626-635.
17. + T regulatory cells. J Immunol 2010, 184:3433-3441.
18. Kappler J.W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987, 49:273-280.
19. Lee D.-S., Aim C., Ernst B., Sprent J., Surh C.D. Thymic selection by single MHC-peptide ligand. Autoreactive T cells are low-affinity cells. Immunity 1999, 10:83-92.
20. Schultz M., Tonkonogy S.L., Sellon R.K., Veltkamp C., Godfrey V.L., Kwan J., et al. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 1999, 276:G1461-G1472.
21. Chinen T., Volchkov P.Y., Chervonsky A.V., Rudensky A.Y. A critical role for regulatory T cell-mediated control of inflammation in the absence of commensal microbiota. J Exp Med 2010, 207:2323-2330.
22. + regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001, 2:301-306.
23. + T cell receptors. Immunity 2004, 21:267-277.
24. Pacholczyk R., Kem J., Singh N., Iwashima M., Kraj P., Ignatowicz L. Nonself-antigens are the cognate specificities of Foxp3 regulatory T cells. Immunity 2007, 27:493-504.
25. + regulatory T cells rescue scurfy mice. Eur J Immunol 2008, 38:1814-1821.
26. + regulatory T cells. Nat Immunol 2003, 4:330-336.
27. Malek T.R., Yu A., Vincek V., Scibelli P., Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002, 17:167-178.
28. Malek T.R. The main function of IL-2 is to promote the development of T regulatory cells. J Leuk Biol 2003, 74:961-965.
29. Malek T.R., Bayer A.L. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004, 4:665-674.
30. Malek T.R. The biology of IL-2. Annu Rev Immunol 2008, 26:453-479.
31. + T cells protect IL-2 receptor α-deficient mice from systemic infection with herpes simplex virus type 2. J Immunol 2000, 165:4552-4560.
32. + T cell homeostasis. J Immunol 2007, 178:1251-1255.
33. Zheng L., Sharma R., Gaskin F., Fu S.M., Ju S.T. A novel role of IL-2 in organ-specific autoimmune inflammation beyond regulatory T cell checkpoint: both IL-2 knockout and Fas mutation prolong lifespan of Scurfy mice but by different mechanisms. J Immunol 2007, 179:8035-8041.
34. Medoff B.D., Thomas S.Y., Luster A.D. T cell trafficking in allergic asthma: the ins and outs. Annu Rev Immunol 2008, 26:205-232.
35. Kamanaka M., Rainbow D., Schuster-Gossler K., Eynon E.E., Chervonsky A.V., Wicker L.S., et al. Amino acid polymorphisms altering the glycosylation of IL-2 do not protect from type 1 diabetes in the NOD mice. Proc Nat Acad Sci USA 2009, 106:11236-11240.
36. Vijayakrishnan L., Slavik J.M., Illes Z., Greenwald R.J., Rainbow D., Greve B., et al. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T-cells. Immunity 2004, 20:563-575.
37. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000, 12:431-440.
38. Serreze D.V., Hamaguchi K., Leiter E.H. Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimm 1989, 2:759-776.
39. Grinberg-Bleyer Y., Baeyens A., You S., Elhage R., Fourcade G., Gregoire S., et al. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med 2010, 207:1871-1878.
40. Chen Z., Benoist C., Mathis D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Nat Acad Sci USA 2005, 102:14735-14740.
41. + T reg cells impinge on autoimmune diabetes. J Exp Med 2005, 202:1387-1397.
42. Sharma R., Ju S.T. Genetic control of the inflammatory T-cell response in regulatory T-cell deficient scurfy mice. Clin Immunol 2010, 136:162-169.
43. Liston A., Siggs O.M., Goodnow C.C. Tracing the action of IL-2 in tolerance to islet-specific antigen. Immunol Cell Biol 2007, 85:338-342.
44. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004, 199:1455-1465.
45. Greenbaum C. A phase I trial of Proleukin and Rapamune in recent-onset type 1 diabetes mellitus. ClinicalTrials.gov (received 9/4/2007, updated on 12/10/2010, accessed on 1/19/2011).
46. Dromey J.A., Lee B.H., Yu H., Young H.E., Thearle D.J., Jensen K.P., et al. Generation and expansion of regulatory human CD4(+) T-cell clones specific for pancreatic islet autoantigens. J Autoimm 2011, 36:47-55.